Remove 2001 Remove Biosimilars Remove Prescription Filling
article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Between December 1, 2018 and January 31, 2019, 65% of erectile dysfunction prescriptions filled were for Viagra or its generic version 12. AstraZeneca’s patent for its top-selling gastroesophageal reflux disease drug was due to expire in 2001.